Complex Litigation Partner and National Practice Group Leader Jacques Smith was quoted in an article discussing healthcare-related fraud by Compliance Week.
The acquisition, valued at approximately $167 million, included 15 single-story office, flex and industrial properties in Chesapeake and Norfolk, Virginia and added more than 1.6 million square feet to the Mid-Atlantic portfolio of DSC Partners.
Arent Fox’s Sports Practice Leader Rich Brand spoke with radio network WTMJ on Wednesday, January 23rd, 2019 on the new naming rights for the Milwaukee Brewers’ Miller Park. The Brewers recently announced that American Family Insurance will take over the naming rights of Miller Park in 2021.
Arent Fox was featured in Alaska Native Village Corporation Association’s (ANVCA) “January 2019 Member Newsletter.”
Bankruptcy and Financial Restructuring group West Coast team leader Aram Ordubegian recently spoke with Business Insurance about Pacific Gas & Electric Co. (PG&E)’s recent filing for Chapter 11 bankruptcy for all its businesses because of the liabilities it faces from catastrophic wildfires.
Arent Fox attorneys D. Jacques Smith, Randall Brater, and Michael Dearington spoke with Bloomberg Law about an upcoming US Supreme Court case and its potential ramifications for False Claims Act cases.
Managing Partner Marci Eisenstein was quoted on the importance of diversity in law firm leadership.
Joel Wallace was quoted on a recent ruling from Federal Judge Reed O’Connor in the Federal District Court in Fort Worth, Texas, that the Affordable Care Act’s (ACA) individual coverage mandate is unconstitutional and, in the absence of the individual mandate, the rest of the ACA cannot stand.
Earlier this month, Arent Fox LLP received the “Best Deal of the Year” award from the Washington DC Economic Partnership for a deal financing the acquisition of a new training center for the Spanish Education and Development Center.
Intellectual Property Practice Group Co-Leader Imron Aly was quoted on how including patents in the U.S. Food and Drug Administration’s “Purple Book” — which lists biological products, including any biosimilar and interchangeable biological products — might affect developers.
On December 5, New York partner Hunter Carter spoke before the Inter-American Commission on Human Rights.
On December 4, Complex Litigation Partner James H. Hulme was elected Vice President of the Council for Court Excellence at the nonprofit’s semi-annual board meeting held in the US District Court for the District of Columbia.
Have optimism and be proactive, Marci Eisenstein advises young women.
Intellectual Property Practice Group Co-Leader Imron Aly described the three key features of the U.S. Food and Drug Administration’s Biosimilar Action Plan: education, interchangeability, and international data sharing.